Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stefan, Sziegoleit"'
Autor:
Peter Bramlage, Sascha R Tittel, Gesine van Mark, Reinhard Welp, Jörg Gloyer, Stefan Sziegoleit, Ralf Barion, Peter M Jehle, Dieter Erath, Stefanie Lanzinger
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction The aims of this study were to characterize insulin-treated individuals aged ≥75 years with type 2 diabetes using basal insulin analogs (BIA) or regular insulins (human insulin (HI)/neutral protamine Hagedorn (NPH)) and to compare the
Externí odkaz:
https://doaj.org/article/ada6db58000c4f9985f7167a9ea4fe8a
Autor:
Gesine van Mark, Sascha R. Tittel, Stefan Sziegoleit, Franz Josef Putz, Mesut Durmaz, Michaela Bortscheller, Ivo Buschmann, Jochen Seufert, Reinhard W. Holl, Peter Bramlage
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 11 (2020)
Background: The clinical profile differs between old and young patients with type 2 diabetes mellitus (T2DM). We explored, based on a large real-world database, patient and disease characteristics and actual treatment patterns by age. Methods: The an
Externí odkaz:
https://doaj.org/article/6a9554b72f074f9c942921076b16a82d
Autor:
Stefanie Lanzinger, Thomas Danne, Stefan Sziegoleit, Julia Mader, Michael Hummel, Benjamin Berlemann, Peter Bramlage
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e0b7fede62b041085d2ab5f7a1ddc80
https://doi.org/10.1055/s-0042-1746253
https://doi.org/10.1055/s-0042-1746253
Autor:
Reinhard W. Holl, Maike Plaumann, Stefan Sziegoleit, Gesine van Mark, Peter Bramlage, Dpv, Bettina Hartmann, Mesut Durmaz, Stefanie Lanzinger, Frank Jürgen Wosch, Dive registry initiatives, Jochen Seufert
Publikováno v:
Acta Diabetologica. 57:229-236
Our study aimed to analyse treatment strategies after failure of initial metformin mono-therapy in adult patients with type-2 diabetes (T2DM). The DIVE and DPV databases were combined and 16,681 adult patients with T2DM and metformin mono-therapy ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab99128af0b64d801c00a733f2724e5d
https://doi.org/10.1007/s00592-019-01409-3
https://doi.org/10.1007/s00592-019-01409-3
Autor:
Franz Josef Putz, Stefan Sziegoleit, Reinhard W. Holl, Peter Bramlage, Mesut Durmaz, Stefanie Lanzinger, Jochen Seufert, Thomas Danne, Michaela Borscheller, Gesine van Mark
Publikováno v:
Advances in Therapy. 36:1628-1641
Insulin glargine 300 U/ml (U300) was registered based on the EDITION clinical trial program. The aim of this database analysis was to describe the profile of adult U300 recipients with type-1 (T1DM) or type-2 diabetes (T2DM). The analysis was based o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499060723dab8b6c10b50dd6c50af991
https://doi.org/10.1007/s12325-019-00983-w
https://doi.org/10.1007/s12325-019-00983-w
Autor:
Stefanie Lanzinger, Reinhard Welp, Sascha R. Tittel, Dieter Erath, Gesine van Mark, Jörg Gloyer, Peter Bramlage, Stefan Sziegoleit, Peter M. Jehle, Ralf Barion
Publikováno v:
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
IntroductionThe aims of this study were to characterize insulin-treated individuals aged ≥75 years with type 2 diabetes using basal insulin analogs (BIA) or regular insulins (human insulin (HI)/neutral protamine Hagedorn (NPH)) and to compare the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31252b4bf6e1b534e49f3099f05b1c51
https://pubmed.ncbi.nlm.nih.gov/34083247
https://pubmed.ncbi.nlm.nih.gov/34083247
Autor:
Reinhard W. Holl, Michaela Bortscheller, Sascha R. Tittel, Franz Josef Putz, Peter Bramlage, Stefan Sziegoleit, Jochen Seufert, Mesut Durmaz, Ivo Buschmann, Gesine van Mark
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism, Vol 11 (2020)
Therapeutic Advances in Endocrinology and Metabolism, Vol 11 (2020)
The clinical profile differs between old and young patients with type 2 diabetes mellitus (T2DM). We explored, based on a large real-world database, patient and disease characteristics and actual treatment patterns by age.
publishedVersion
publishedVersion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76be31a20c7f60d9dbba116e2b069447
Autor:
Michael Hummel, Artur Zimmermann, Reinhard W. Holl, Barbara Bohn, Hans Martin Reuter, Jörg Gloyer, Thomas Danne, Reinhard Welp, Stefan Sziegoleit, Peter Bramlage, Christian Wagner, Matthias Kaltheuner
Publikováno v:
Wiener Medizinische Wochenschrift. 168:415-422
Glargin U300 (Gla-300) ist eine Weiterentwicklung von Glargin U100 (Gla-100) und seit 2015 in Deutschland und Osterreich erhaltlich. Ziel war es zu untersuchen, wie sich auf Gla-300 ein-/umgestellte Patienten von zeitgleich auf Gla-100 eingestellte P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28e7b54723717998e85b59f25c39075e
https://doi.org/10.1007/s10354-017-0589-8
https://doi.org/10.1007/s10354-017-0589-8
Autor:
Barbara, Bohn, Peter, Bramlage, Christian, Wagner, Matthias, Kaltheuner, Reinhard, Welp, Stefan, Sziegoleit, Artur, Zimmermann, Hans Martin, Reuter, Michael, Hummel, Jörg, Gloyer, Reinhard W, Holl, Thomas, Danne
Publikováno v:
Wiener medizinische Wochenschrift (1946). 168(15-16)
Glargine U300 (Gla-300) is a further development of glargine U100 (Gla-100). Since 2015, Gla-300 has been available in Germany and Austria. We compared patients initiating therapy with Gla-300 with patients starting with Gla-100. Moreover, it was inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::651cc5d9c9f0ad1b90c0f4638880ccca
https://pubmed.ncbi.nlm.nih.gov/28828553
https://pubmed.ncbi.nlm.nih.gov/28828553